BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6733561)

  • 1. Fractionation in radiation therapy: theoretical basis, experimental, and clinical studies.
    Shank B; Chu FF
    Cancer Invest; 1984; 2(2):165-76. PubMed ID: 6733561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated fractionation vs hyperfractionation: rationales for several treatments per day.
    Thames HD; Peters LJ; Withers HR; Fletcher GH
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):127-38. PubMed ID: 6833014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma.
    Fowler JF; Ritter MA
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):521-9. PubMed ID: 7751194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent total doses for different fractionation schemes, based on the linear quadratic model.
    Muller-Runkel R; Vijayakumar S
    Radiology; 1991 May; 179(2):573-7. PubMed ID: 2014314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered fractionation radiation therapy for gynecologic cancers.
    Wang CC
    Cancer; 1987 Oct; 60(8 Suppl):2064-7. PubMed ID: 3652026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.
    Marks LB; Dewhirst M
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1377-83. PubMed ID: 1938539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.
    Thames HD; Withers HR; Peters LJ; Fletcher GH
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):219-26. PubMed ID: 7085377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor radioresponsiveness versus fractionation sensitivity.
    Thames HD; Suit HD
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):687-91. PubMed ID: 3700173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
    Yang Y; Xing L
    Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic basis for altered fractionation schemes.
    Withers HR
    Cancer; 1985 May; 55(9 Suppl):2086-95. PubMed ID: 3919923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superfractionation: its rationale and anticipated benefits.
    Douglas BG
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1143-53. PubMed ID: 7118617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cell kinetics of human solid tumors and biological basis for fractionated radiotherapy].
    Sasaki T; Mashiyama S
    Gan No Rinsho; 1985 Sep; 31(12):1502-11. PubMed ID: 4079038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid tumor models for the assessment of different treatment modalities: XXV. Comparison of the effect of one radiation fraction per day with multiple fractions per day (MFD) given either continuously or intermittently on tumor response and normal tissue reaction.
    Looney WB; Hopkins HA
    Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):203-10. PubMed ID: 3949571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
    Stuschke M; Budach V; Stüben G; Streffer C; Sack H
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: total doses in fractionated radiotherapy--implications of new radiobiological data.
    Fowler JF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Aug; 46(2):103-20. PubMed ID: 6381354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
    Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
    Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rational dose fractionation schedule 1. Each fractional dose].
    Masuda K; Matsuura K; Miyoshi M; Uehara T
    Gan No Rinsho; 1985 Sep; 31(12):1520-4. PubMed ID: 4079040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute normal tissue tolerance to 7 day per week accelerated fractionation.
    Lipsett JA; Desai K; Pezner R; Vora N; Chong LM; Archambeau JO
    Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1049-52. PubMed ID: 6746345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.